Blomqvist C - Search Results

1

Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors.

Jahkola T, Toivonen T, von Smitten K, Virtanen I, Wasenius VM, Blomqvist C. Jahkola T, et al. Among authors: blomqvist c. Br J Cancer. 1999 Apr;80(1-2):167-74. doi: 10.1038/sj.bjc.6690336. Br J Cancer. 1999. PMID: 10389993 Free PMC article.

2

The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial.

Blomqvist C, Tiusanen K, Elomaa I, Rissanen P, Hietanen T, Heinonen E, Gröhn P. Blomqvist C, et al. Br J Cancer. 1992 Dec;66(6):1171-6. doi: 10.1038/bjc.1992.430. Br J Cancer. 1992. PMID: 1457360 Free PMC article. Clinical Trial.

3

Adjuvant hormone therapy in breast cancer.

Blomqvist CP, Elomaa I, Rissanen P. Blomqvist CP, et al. Ann Med. 1992 Apr;24(2):91-6. doi: 10.3109/07853899209148333. Ann Med. 1992. PMID: 1535200

4

Type III collagen metabolism in soft tissue sarcomas.

Wiklund TA, Elomaa I, Blomqvist CP, Risteli L, Risteli J. Wiklund TA, et al. Among authors: blomqvist cp. Br J Cancer. 1992 Feb;65(2):193-6. doi: 10.1038/bjc.1992.40. Br J Cancer. 1992. PMID: 1739616 Free PMC article.

5

Postirradiation sarcoma. Analysis of a nationwide cancer registry material.

Wiklund TA, Blomqvist CP, Räty J, Elomaa I, Rissanen P, Miettinen M. Wiklund TA, et al. Among authors: blomqvist cp. Cancer. 1991 Aug 1;68(3):524-31. doi: 10.1002/1097-0142(19910801)68:3<524::aid-cncr2820680313>3.0.co;2-e. Cancer. 1991. PMID: 2065271

6

The response evaluation of bone metastases in mammary carcinoma. The value of radiology, scintigraphy, and biochemical markers of bone metabolism.

Blomqvist C, Elomaa I, Virkkunen P, Porkka L, Karonen SL, Risteli L, Risteli J. Blomqvist C, et al. Cancer. 1987 Dec 15;60(12):2907-12. doi: 10.1002/1097-0142(19871215)60:12<2907::aid-cncr2820601211>3.0.co;2-b. Cancer. 1987. PMID: 3315177 Clinical Trial.

7

Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma.

Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius VM, Niskanen E, Nordling S, Reed JC. Krajewski S, et al. Among authors: blomqvist c. Cancer Res. 1995 Oct 1;55(19):4471-8. Cancer Res. 1995. PMID: 7671262

8

The prognosis of stage III breast cancer treated with postoperative radiotherapy and adriamycin-based chemotherapy with and without tamoxifen. Eight year follow-up results of a randomized trial.

Saarto T, Blomqvist C, Tiusanen K, Gröhn P, Rissanen P, Elomaa I. Saarto T, et al. Among authors: blomqvist c. Eur J Surg Oncol. 1995 Apr;21(2):146-50. doi: 10.1016/s0748-7983(95)90204-x. Eur J Surg Oncol. 1995. PMID: 7720887 Clinical Trial.

9

Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?

Hietanen P, Blomqvist C, Wasenius VM, Niskanen E, Franssila K, Nordling S. Hietanen P, et al. Among authors: blomqvist c. Br J Cancer. 1995 May;71(5):1029-32. doi: 10.1038/bjc.1995.198. Br J Cancer. 1995. PMID: 7734295 Free PMC article. Clinical Trial.

10

Measurement of growth rate of lung metastases in 21 patients with bone or soft-tissue sarcoma.

Blomqvist C, Wiklund T, Tarkkanen M, Elomaa I, Virolainen M. Blomqvist C, et al. Br J Cancer. 1993 Aug;68(2):414-7. doi: 10.1038/bjc.1993.351. Br J Cancer. 1993. PMID: 8347499 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

634 results

Search Page